← All diseases
Cancer
Non-Hodgkin lymphoma
Would you like to receive a message when there is new research on Non-Hodgkin lymphoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence above each publication explains what was studied — and you receive a notification as soon as new research on Non-Hodgkin lymphoma is available. View what Premium costs.
Publications and studies (2185)
- Diffuse Plane Xanthoma. (2026/07/28) ♡
- Erythema Elevatum Diutinum. (2026/07/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Bilateral Adrenal Lymphoma Revealed by Adrenal Insufficiency: From Constitutional Symptoms to Crisis. (2026/07/28) ♡
- Extranodal involvement defines distinct immune-molecular phenotypes and clinical outcomes in diffuse large b-cell lymphoma. (2026/07/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CD19 CAR-T cell therapy in large B-cell lymphoma: clinical evidence, resistance, toxicity, and precision strategies. (2026/07/24) ♡
- Potential heterogeneity of epcoritamab associated adverse events in demographics and dosing regimens. (2026/07/23) ♡
- Tumoral immune microenvironment profiling in B-cell non-Hodgkin lymphoma stratifies patients in different prognostic groups. (2026/07/23) ♡
- Baseline systemic immune-inflammation index and a novel FLIPI-SII model predict POD24 and long-term survival in grade 1-3a follicular lymphoma. (2026/07/23) ♡
- Role of late-onset smoking in super-aged patients with diffuse large B-cell lymphoma: a real-world study in China between 2010 and 2024. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas. (2026/07/22) ♡
- Targeting NOP14 remodels the tumor immune microenvironment and enhances the antitumor efficacy of PD-1 blockade in DLBCL. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cellular and molecular aberrations generating new immunotherapeutic approaches in mycosis fungoides and Sézary syndrome: a comprehensive review of literature. (2026/07/22) ♡
- Real-World Outcomes of Frontline Multimodal Treatment Strategies for Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: A Single-Center Vietnamese Cohort Study. (2026/07/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma. (2026/07/17) ♡
- Patient Perspectives on Non-Hodgkin Lymphoma: A Qualitative Study to Guide Selection of Clinical Trial Endpoints. (2026/07/17) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Synchronous rectal cancer and extranodal NK/T-cell lymphoma, nasal type: A case report. (2026/07/17) ♡
- Geriatric Assessment in Patients Aged 70 Years and Older Considered for CAR T-Cell Therapy: A Retrospective Study. (2026/07/16) ♡
- Adverse event reporting patterns of rituximab and obinutuzumab in B-cell non-Hodgkin lymphoma: a FAERS pharmacovigilance study. (2026/07/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Inflammasomes in Sjögren's Disease: Exploring the Therapeutic Value. (2026/07/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review. (2026/07/15) ♡
- The CD19-4-1BBL antibody fusion protein unleashes the immune system against high-risk chronic lymphocytic leukemia. (2026/07/15) ♡
- Proteomics and transcriptomics reveal molecular subtypes and biomarkers of advanced cutaneous T-cell lymphoma. (2026/07/15) ♡
- Persistent racial and socioeconomic inequities in mycosis fungoides survival: a population-based study. (2026/07/15) ♡
- Renal Involvement in Indolent and Aggressive B-Cell Neoplasms: A Comparative Study of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Diffuse Large B-Cell Lymphoma. (2026/07/14) ♡
- Global welfare burden of hematologic malignancies from 2015 to 2023. (2026/07/14) ♡
- A Parent-Delivered Foot Bath Intervention for Chemotherapy-Related Fatigue in Children with Cancer: A Family-Centered Randomized Controlled Trial. (2026/07/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Peptide-Drug Conjugates for Targeted Delivery in Hematological Malignancies: From Design Principles to Clinical Application. (2026/07/13) ♡
- C-POEM as a therapeutic approach for cricopharyngeal achalasia. (2026/07/13) ♡
- A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen. (2026/07/10) ♡
- Prophylactic PEG-rhG-CSF Reduces Febrile Neutropenia in Pediatric Hematological Malignancies Compared with Daily rhG-CSF. (2026/07/09) ♡
- From Cure to Combat: Deployment After Lymphoma. (2026/07/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG PET/CT) in the Characterization of Massive Cardiac Infiltration by Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS). (2026/07/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Adrenals Under Silent Siege: Diffuse Large B-Cell Lymphoma Presenting as Addisonian Crisis. (2026/07/07) ♡
- Glasgow Prognostic Score and Gustave Roussy Immune Score in Hodgkin Lymphoma: Survival Associations and Limited Incremental Prognostic Value Beyond the International Prognostic Score. (2026/07/02) ♡
- Autologous Stem Cell Transplantation Of HIV-Positive Plasmablastic Lymphoma - Case Series. (2026/07/01) ♡
- Clinicopathological Characteristics and Expressor Patterns of C-MYC and EBV in Large B Cell Lymphoma. (2026/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A Case of B-lymphoblastic Lymphoma with MYC Rearrangement Mimicking Burkitt Lymphoma. (2026/07/01) ♡
- Real-world outcomes of endoscopic ultrasound-guided tissue acquisition for actionable diagnosis in suspected primary or recurrent lymphoma. (2026/07/01) ♡
- Clinical characteristics of primary gastrointestinal lymphoma presenting with gastrointestinal bleeding. (2026/07/01) ♡
- Prognostic Value of Semi-Quantitative Metabolic Parameters on [18F]FDG PET/CT in Patients with Diffuse Large B-Cell Lymphoma at Diagnosis. (2026/07/01) ♡
- Mental Distress, Fatigue and Executive Function in Adult Survivors of Childhood Leukemia and Non-Hodgkin Lymphoma. (2026/07/01) ♡
- Cancer Burden in Bangladesh: Age- and Sex-Specific Incidence, Prevalence, Mortality, and Forecasts Up to 2050. (2026/07/01) ♡
- Cancer Distribution Pattern in the City of Kenitra, Morocco (2017-2022): A Pathology-Based Study. (2026/07/01) ♡
- Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers. (2026/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [PRIMARY MALIGNANT LYMPHOMA OF THE RENAL PELVIS : A CASE REPORT]. (2026/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Synchronous Follicular Lymphoma and Lung Adenocarcinoma-A Case Report]. (2026/07/01) ♡
- Real-world outcomes of T cell lymphoma in a tertiary cancer center in Saudi Arabia. (2026/07/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Tumor Genomic Biomarkers as Prognostic Modifiers of Outcomes Following CD19 CAR T-Cell Therapy in Aggressive Large B-Cell Lymphoma: A Systematic Review and Exploratory Meta-Analysis. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. GZ21T as an emerging topical dermatologic therapy: A literature review. (2026/06/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. When "Metastatic Disease" Is Not Metastatic: Diffuse Large B-cell Lymphoma Presenting With a Perisplenic Mass, Pulmonary Masses, Pleural Effusion, and Retroperitoneal Lymphadenopathy. (2026/06/30) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.